CSL FPO (ASX: CSL) Share Price and News
Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health and help people with life-threatening medical conditions live full lives.
While the company has been in operation for more than a century, CSL shares were first listed on the ASX in 1994 within the healthcare sector – today, CSL sits as one of the largest companies on the ASX. The CSL share price has risen exponentially since first listing on the ASX and is now considered a traditional growth stock – CSL is known to lift profit, year-on-year, and invest much of it back into research and development and capital expenditure.
CSL’s operational businesses include CSL Behring and Seqirus, and the company operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
CSL FPO (ASX: CSL) Latest News
Tristan Harrison | January 23, 2020 12:29pm
The share price of LIC Milton Corporation Limited (ASX:MLT) is down after reporting its half-year result, is it a buy? More »
Phil Harpur | January 23, 2020 11:34am
Why ResMed Inc (ASX: RMD) and these 2 other ASX 100 healthcare shares are my top picks in the sector to buy and hold... More »
Brendon Lau | January 22, 2020 12:33pm
The golden run in the Polynovo Ltd (ASX: PNV) share price continues with the stock hitting a new record high and topping the S&P/ASX... More »
Kenneth Hall | January 21, 2020 11:12am
While ASX 200 blue chip shares like CSL Limited (ASX: CSL) are at record highs, this leading broker thinks we could be paying too... More »
Tristan Harrison | January 21, 2020 8:37am
2020 has been extremely eventful already, what’s in store for the ASX share market for the rest of the year? More »
Tristan Harrison | January 20, 2020 11:38am
LIC Australian Foundation Investment Co.Ltd. (ASX:AFI) has reported its FY20 half-year result, is the share price a buy? More »